Moran Amit, Surgeon-Scientist in the Department of Head and Neck Surgery and the Department of Genomic Medicine at MD Anderson Cancer Center shared a post on LinkedIn:
“When you are in the number 1 cancer center in the world, being named amongst the top 3 abstracts, is very meaningful.
Only possible here UT MD Anderson.
In this trial, we wanted to investigate whether a simple, targeted injection of immunotherapy directly into the lesion could shrink it and retrain the immune system to PPREVENT oral cancer. If successful, we’re not just treating a lesion; we’re giving patients back their voice.”
Other articles about MD Anderson on OncoDaily.